Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.
This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,336 studies in total at the last sync on 06 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.
This page shows the 10 of those studies with a site in Macquarie.
6 of the 10 studies on this page are recruiting new participants as of the 06 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.
| Phase | Studies | Recruiting | Share |
|---|---|---|---|
| Phase 1/2 | 2 | 2 | 20% |
| Phase 2 | 2 | 0 | 20% |
| Phase 3 | 2 | 1 | 20% |
| Not applicable | 1 | 0 | 10% |
| Observational | 1 | 1 | 10% |
| Phase 1 | 1 | 1 | 10% |
| Phase EARLY_PHASE1 | 1 | 1 | 10% |
| Lead sponsor | Studies | Recruiting |
|---|---|---|
| Anders Aneman | 1 | 1 |
| AP Biosciences Inc. | 1 | 1 |
| Cochlear | 1 | 0 |
| Exelixis | 1 | 0 |
| Merck Sharp & Dohme LLC | 1 | 1 |
| Multitude Therapeutics Inc. | 1 | 1 |
| Olema Pharmaceuticals, Inc. | 1 | 1 |
| Shanghai Allink Biotherapeutics Co., Ltd. | 1 | 1 |
| Syntara | 1 | 0 |
| Tectonic Therapeutic | 1 | 0 |
